These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Citrate-Saline-Formulated mRNA Delivery into the Heart Muscle with an Electromechanical Mapping and Injection Catheter Does Not Lead to Therapeutic Effects in a Porcine Chronic Myocardial Ischemia Model. Järveläinen N; Halonen P; Nurro J; Hätinen OP; Korpela H; Mäkinen P; Gan LM; Fritsche-Danielson R; Ylä-Herttuala S Hum Gene Ther; 2021 Oct; 32(19-20):1295-1307. PubMed ID: 34494459 [TBL] [Abstract][Full Text] [Related]
4. Correlation of functional recovery with myocardial blood flow, glucose uptake, and morphologic features in patients with chronic left ventricular ischemic dysfunction undergoing coronary artery bypass grafting. Depré C; Vanoverschelde JL; Gerber B; Borgers M; Melin JA; Dion R J Thorac Cardiovasc Surg; 1997 Feb; 113(2):371-8. PubMed ID: 9040632 [TBL] [Abstract][Full Text] [Related]
12. Interaction between two predictors of functional outcome after revascularization in ischemic cardiomyopathy: left ventricular volume and amount of viable myocardium. Mandegar MH; Yousefnia MA; Roshanali F; Rayatzadeh H; Alaeddini F J Thorac Cardiovasc Surg; 2008 Oct; 136(4):930-6. PubMed ID: 18954632 [TBL] [Abstract][Full Text] [Related]
13. Myocardial transfection of hypoxia inducible factor-1alpha via an adenoviral vector during coronary artery bypass grafting. - A multicenter phase I and safety study -. Kilian EG; Sadoni S; Vicol C; Kelly R; van Hulst K; Schwaiger M; Kupatt C; Boekstegers P; Pillai R; Channon K; Hetzer R; Reichart B Circ J; 2010 May; 74(5):916-24. PubMed ID: 20215699 [TBL] [Abstract][Full Text] [Related]
14. High-dose plasmid-mediated VEGF gene transfer is safe in patients with severe ischemic heart disease (Genesis-I). A phase I, open-label, two-year follow-up trial. Favaloro L; Diez M; Mendiz O; Janavel GV; Valdivieso L; Ratto R; Garelli G; Salmo F; Criscuolo M; Bercovich A; Crottogini A Catheter Cardiovasc Interv; 2013 Nov; 82(6):899-906. PubMed ID: 22777825 [TBL] [Abstract][Full Text] [Related]
15. Intramyocardial plasmid-encoding human vascular endothelial growth factor A165/basic fibroblast growth factor therapy using percutaneous transcatheter approach in patients with refractory coronary artery disease (VIF-CAD). Kukuła K; Chojnowska L; Dąbrowski M; Witkowski A; Chmielak Z; Skwarek M; Kądziela J; Teresińska A; Małecki M; Janik P; Lewandowski Z; Kłopotowski M; Wnuk J; Rużyłło W Am Heart J; 2011 Mar; 161(3):581-9. PubMed ID: 21392615 [TBL] [Abstract][Full Text] [Related]
16. Effects of intramyocardial injection of phVEGF-A165 as sole therapy in patients with refractory coronary artery disease--12-month follow-up: angiogenic gene therapy. Sarkar N; Rück A; Källner G; Y-Hassan S; Blomberg P; Islam KB; van der Linden J; Lindblom D; Nygren AT; Lind B; Brodin LA; Drvota V; Sylvén C J Intern Med; 2001 Nov; 250(5):373-81. PubMed ID: 11887971 [TBL] [Abstract][Full Text] [Related]
17. Effect of coronary bypass grafting onto the site of old myocardial infarction and the recovery of cardiac function. Ando H; Tanaka J; Hisahara M; Umesue M; Shirota T Cardiovasc Surg; 1998 Oct; 6(5):511-9. PubMed ID: 9794273 [TBL] [Abstract][Full Text] [Related]
18. [Results of coronary surgery in mildly symptomatic patients with left ventricular dysfunction, multivessel disease and stenotic single residual patent vessel]. Dalle Mule J; Zingone B; Bilardo G; Sponga B; Pellegrini P; Branchini B; Burelli C; Zanuttini D; Martinelli F; Perelli R G Ital Cardiol; 1995 May; 25(5):561-74. PubMed ID: 7642061 [TBL] [Abstract][Full Text] [Related]
19. Decision making and results of coronary artery bypass grafting for patients with poor left ventricular function. Uyar IS; Sahin V; Akpinar MB; Abacilar F; Yurtman V; Okur FF; Ates M; Tavli T Heart Surg Forum; 2013 Jun; 16(3):E118-24. PubMed ID: 23803233 [TBL] [Abstract][Full Text] [Related]
20. Impact of remote ischemic preconditioning preceding coronary artery bypass grafting on inducing neuroprotection (RIPCAGE): study protocol for a randomized controlled trial. Gasparovic H; Kopjar T; Rados M; Anticevic A; Rados M; Malojcic B; Ivancan V; Fabijanic T; Cikes M; Milicic D; Gasparovic V; Biocina B Trials; 2014 Oct; 15():414. PubMed ID: 25348157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]